Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
Cancer Treatment Reviews|December 12, 2025
Endocrine-based strategies after CDK4/6 inhibitors in biomarker-selected subgroup of hormone receptor positive advanced breast cancer: A systematic review and network meta-analysisAlicia Escudero, Meritxell Bellet, Cristina Saura, et al.
Cancers|April 3, 2021
Endocrine-Based Treatments in Clinically-Relevant Subgroups of Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Systematic Review and Meta-AnalysisFrancesco Schettini, Mario Giuliano, Fabiola Giudici, et al.
Breast Cancer Research and Treatment|June 6, 2020
Metabolic syndrome and early stage breast cancer outcome: results from a prospective observational studyGiuseppe Buono, Anna Crispo, Mario Giuliano, et al.
Cancer Treatment Reviews|May 22, 2026
Central nervous system and leptomeningeal metastases in patients with HER2-positive breast cancer: A comprehensive review and therapeutic algorithm proposalAldo Caltavituro, Roberto Buonaiuto, Alessandra Longobardi, et al.
Ebiomedicine|June 23, 2021
Oestrogen receptor activity in hormone-dependent breast cancer during chemotherapyNuria Chic, Francesco Schettini, Fara Brasó-Maristany, et al.
Cancer Immunology, Immunotherapy : CII|February 1, 2025
Blood-based prognostic scores and early dynamics under immunotherapy to select patients with metastatic solid tumors for continuing immune check-point inhibition: a prospective longitudinal studyJavier García-Corbacho, Alberto Indacochea, Iván Victoria, et al.
Cells|April 12, 2024
CD99 Expression and Prognostic Impact in Glioblastoma: A Single-Center Cohort StudyAndrea Rocca, Fabiola Giudici, Carmine Antonio Donofrio, et al.
Scientific Reports|July 11, 2024
Comparative biological activity of palbociclib and ribociclib in hormone receptor-positive breast cancerNatàlia Lorman-Carbó, Olga Martínez-Sáez, Aranzazu Fernandez-Martinez, et al.
NPJ Breast Cancer|February 4, 2021
Circulating tumor DNA dynamics in advanced breast cancer treated with CDK4/6 inhibition and endocrine therapyOlga Martínez-Sáez, Tomás Pascual, Fara Brasó-Maristany, et al.
Frontiers in Oncology|July 15, 2021
Clinical, Radiometabolic and Immunologic Effects of Olaparib in Locally Advanced Triple Negative Breast Cancer: The OLTRE Window of Opportunity TrialFrancesco Schettini, Silvia Paola Corona, Fabiola Giudici, et al.
Pageof 9